NL-OMON23631招募中不适用
Biomarker-based Early Anti-inflammatory Therapy for severe COVID-19
Prof. Dr. L.G. Visser0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 250
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Hospitalized patient with PCR confirmed COVID-19 infection
- •- Eighteen years or older
排除标准
- •- Not able to give consent by representative of the subject
研究者
相似试验
招募中
不适用
Biomarkers in InfectionSepsisInfectionInflammationNCT02545478Beth Israel Deaconess Medical Center4,200
已完成
不适用
Determining the Presence of RAP in Orthognathic Patients and Its Effect on Root Resorption by BiomarkersClass III MalocclusionRoot ResorptionNCT04823325Bezmialem Vakif University13
已完成
不适用
Biomarker-based Early Anti-inflammatory Therapy for severe COVID-19Coronavirus infectionCOVID-191004743810024970NL-OMON55200eids Universitair Medisch Centrum275
招募中
不适用
Biomarkers of inflammation / Medical RNomicsC34J18N39B54J45J44Malignant neoplasm of bronchus and lungPneumonia, organism unspecifiedOther disorders of urinary systemUnspecified malariaOther chronic obstructive pulmonary diseaseAsthmaDRKS00012518Philipps-Universität MarburgInstitut für Lungenforschung130
已完成
不适用
Investigations for biomarkers in inflammatory diseases like rheumatoid arthritis during fasting and dietM05E88.9Seropositive rheumatoid arthritisMetabolic disorder, unspecifiedDRKS00014097Charité Campus Charité Mitte30